Information about the impact of HIV treatment on viral load, the immune system, other health conditions, mortality and quality of life. The life expectancy of people living with HIV is similar to that of other people, as long as they get the right medical treatment and care.

Treatment outcomes and life expectancy: latest news

Treatment outcomes and life expectancy resources

Treatment outcomes and life expectancy features

Treatment outcomes and life expectancy in your own words

Treatment outcomes and life expectancy news from aidsmap

More news

Treatment outcomes and life expectancy news selected from other sources

  • Wider ART Rollout Tied to Declines in HIV Mortality in Kenya

    Both all-cause mortality and mortality among HIV-positive people dropped in Western Kenya following a scale-up of antiretroviral therapy (ART), a researcher said here. From 2011 to 2016, all-cause mortality dropped from 10.0 per 1,000 person years (95% CI 8.4-11.7) to 7.5 per 1,000 person years (95% CI 5.8-9.1), reported Emily C. Zielinski-Gutierrez, DrPH, of the CDC.

    12 March 2019 | MedPage Today
  • Uganda: Financial incentives do not boost HIV viral suppression rate

    Financial incentives had no effect on viral suppression among HIV-positive adults in Uganda, according to a recent study. Researchers said these findings suggest a need for better interventions to promote the achievement of viral suppression.

    25 January 2019 | Healio
  • Starting HIV treatment at diagnosis slashes drop out, drug failure rates, China study finds

    Patients diagnosed with HIV who started antiretroviral treatment within 30 days had significantly lower rates of dropping out of treatment, and higher rates successful treatment, than those who started later, particularly those who started more than three months after their diagnosis, a study in China has found.

    04 June 2018 | Science Speaks
  • Continuous Medicaid Coverage Essential for People Living With HIV

    Implementing initiatives to maintain Medicaid enrollment and expedite re-enrollment and having alternate resources available during gap times may be important to ensure continuous antiretroviral therapy (ART) to optimize HIV outcomes, according to a study recently published in the Journal of Acquired Immune Deficiency Syndromes.

    01 June 2018 | Infectious Disease Advisor
  • New findings on inflammation & how it affects people with HIV

    “There is a large set of adverse events that HIV-infected individuals suffer from that appear to be associated with inflammation,” lead study author Brian Hart told BETA. “These events are relatively common and can affect length and quality of life.”

    27 April 2018 | BETA blog
  • Why Don’t Blacks With HIV Fare as Well as Whites on Treatment?

    According to a recent study, such a disparity persists even when access to care for the virus is equal.

    13 April 2018 | Poz
  • What's it like being in a HIV mixed diagnosis relationship?

    'I spent a lot of time researching the condition and I learnt quite quickly that people with HIV live the same length of time as people without. The most important fact is that if your partner is on HIV medication, there's zero chance of being infected."

    15 November 2017 | Metro
  • Americans Are Still Dying From AIDS. We Need More HIV Prevention

    The ravages of advanced HIV infection, the nearly-forgotten news items of the 1980s like PCP — Pneumocystis pneumonia -- and Kaposi Sarcoma, are still afflicting those diagnosed late, even if this fact is no longer news.

    07 November 2017 | WBUR
  • HIV life expectancy 'near normal' thanks to new drugs

    Newer medications have fewer side effects and are more efficient at stopping the virus.

    11 May 2017 | BBC Health
  • New Study Reveals why people with HIV are more likely to develop Emphysema

    Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema in their lifetime. Now, new research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

    10 May 2017 | Weill Cornell Medicine
More news
Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.